The Ministry of Health of the Russian Federation has granted a temporary registration certificate to Covid-19 treatment, Avifavir, produced by the Russian Direct Investment Fund (RDIF) and ChemRar Group. Said to be the country’s first Covid-19 drug, Avifavir is a generic version of an anti-flu drug, Avigan, which has been used in Japan since 2014 to treat severe forms of influenza. Pharmaceutical Technology
Monday, June 1, 2020
Russia grants temporary approval for Avifavir to treat Covid-19
The Ministry of Health of the Russian Federation has granted a temporary registration certificate to Covid-19 treatment, Avifavir, produced by the Russian Direct Investment Fund (RDIF) and ChemRar Group. Said to be the country’s first Covid-19 drug, Avifavir is a generic version of an anti-flu drug, Avigan, which has been used in Japan since 2014 to treat severe forms of influenza. Pharmaceutical Technology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment